Temsirolimus is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is approved to treat renal cell carcinoma. It is also being studied in the treatment of other types of cancers, including multiple myeloma.

SparkCures ID 148
Developed By Pfizer
Generic Name Temsirolimus
Additional Names Torisel, CCI-779
Treatment Classifications
  • Mammalian Target of Rapamycin (mTOR) Inhibitor

Clinical Trials


There are no resources, links or videos to display for this treatment.